Cookies remember you so we can ensure to give you the best experience possible. By using this website or closing this message, you are agreeing to our cookies and policies

Do not show this message again
UK Insights

Global vaccination crisis?

Markus Kuehl


Health 19.05.2015 / 17:30

Global Donor Vaccine Program Crisis NEW

Kantar Health looks at the challenges facing the vaccines market

The field of vaccines and immunization has been transformed globally over the last 40 years; however, the system is now in crisis, with vaccine shortages and R&D efforts considered costly and lengthy.

GAVI, the Global Vaccine Alliance, has proven to be a strong catalyst for vaccination in developing countries and continues to make an extremely important contribution to preventative medicine, and to social and economic development. But, overall, vaccination coverage levels remain stagnant and 20% of the worldwide birth cohort does not receive a single vaccine, despite some of the vaccines costing only a few cents per dose.

The Ebola epidemic and the lack of new antibiotics, highlight the problem as R&D manufacturers invest in treatments for more lucrative diseases, rather than develop vaccines to address emerging or neglected diseases.

In order to remain healthy, the vaccination ecosystem needs to provide returns on investment for donors (such as: Bill & Melinda Gates Foundation, USAID, NORAD and others) but also manufacturers:

  • Multiple suppliers are needed to avoid sole supplier situations and to help secure supply.
  • The development of vaccines for diseases that predominantly or exclusively burden poorer countries and funding for R&D activities must be secured.
  • The support of existing vaccination programs also needs to remain in focus. Supply shortages have been identified by SAGE (Strategic Advisory Group of Experts on Immunization) as a key hurdle in achieving vaccination goals. The current vaccine market appears to be not attractive enough for new market entrants to fill this gap.
  • Ongoing support is needed to sustain the vaccination policy efforts when a country no longer qualifies for GAVI funding - countries with a gross national income per capita above the eligibility threshold are no longer be available for funding.

In a world in which thousands of children continue to die from preventable infectious diseases every year, failure is not an option.

Click on the slide on the right hand side to expand it, or download the white paper below.

Source : Kantar Health

Editor's Notes

Journalists, to interview Markus Kuehl or for more information please contact us.

Latest Stories

The latest grocery market share figures from Kantar Worldpanel show supermarket sales increased in value by 3.1% year on year.

Research by Kantar shows that 37% of British adults consider their diets to be very healthy. Are they right?

Annual Media & Digital Predictions from Kantar Millward Brown highlight continued evolutions in branded storytelling, cross-media measurement and ROI.

2017’s most effective ads combine great storytelling that connects emotionally, with relevant and motivating messaging, says Kantar Millward Brown.

The latest smartphone OS data from Kantar Worldpanel ComTech reveals that iOS share fell in key markets

Related Content